Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. cuba. invest. bioméd ; 39(3): e679, jul.-set. 2020. tab, graf
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1138940

RESUMO

Introducción: Los indicadores bibliométricos ayudan a evaluar la repercusión de la evidencia disponible. Objetivo: Comparar el Factor de Impacto, el Eigenfactor Score, SCImago Journal & Country Rank y el Source Normalized Impact per Paper, en revistas de farmacología, toxicología y farmacia de mayor impacto a nivel mundial en sus ediciones 2018. Métodos: Estudio descriptivo, retrospectivo, obtenido del análisis bibliométrico. Se realizó una búsqueda electrónica en el Instituto para la Información Científica en revistas incluidas en el Journal Citation Report (https://scijournal.org/), para la obtención del Factor de Impacto y Puntuación del factor propio, en el portal web oficial de Scimago Journal para acceder al SCImago Journal & Country Rank (https://www.scimagojr.com/) y para la obtención del Source Normalized Impact per Paper en el portal Journal Indicators (https://www.journalindicators.com/indicators), edición 2018. Los datos se cuantificaron mediante el paquete estadístico STATA v.14.0. Se analizó las características de las revistas para cada indicador, la correlación entre las variables se estimó mediante la prueba de Spearman. Resultados: Se analizaron 100 revistas, todas indizadas en las bases de datos seleccionadas. Los coeficientes de correlación de Spearman obtenidos entre los indicadores estudiados fueron: Factor de Impacto y Puntuación del factor propio = 0,246; Factor de Impacto y Scimago Journal & Country Rank = 0,758; Factor de impacto y Source Normalized Impact per Paper = 0,680; Puntuación del factor propio y Scimago Journal & Country Rank = 0,367, Puntuación del factor propio y Source Normalized Impact per Paper = 0,264 y SCImago Journal & Country Rank y Source Normalized Impact per Paper = 0,541; además fueron estadísticamente significativas (p < 0,05). Conclusiones: Se encontró una correlación moderada a alta y significativa entre el factor de impacto, Puntuación del factor propio, SCImago Journal & Country Rank y el Source Normalized Impact per Paper(AU)


Introduction: Bibliometric indicators are useful to evaluate the impact of the evidence available. Objective: Compare the Impact Factor, the Eigenfactor Score, the SCImago Journal & Country Rank and the Source Normalized Impact per Paper of the highest worldwide impact pharmacology, toxicology and pharmacy journals in their 2018 editions. Methods: A retrospective descriptive study was performed of data obtained from bibliometric analysis. An electronic search was conducted at the Scientific Information Institute of journals included in the Journal Citation Report (https://scijournal.org/) to obtain the Impact Factor and the Eigenfactor Score, in the SCImago Journal official web portal to access the SCImago Journal & Country Rank (https://www.scimagojr.com/) and in Journal Indicators (https://www.journalindicators.com/indicators) 2018 edition to obtain the Source Normalized Impact per Paper. Data were quantified with the statistical package STATA v.14.0. An analysis was done of the characteristics of the journals for each indicator, whereas correlation between the variables was estimated with Spearman's test. Results: A total 100 journals were examined, all of them indexed in the databases selected. Examination of the indicators studied revealed the following Spearman's correlation coefficients: Impact Factor and Eigenfactor Score = 0,246; Impact Factor and SCImago Journal & Country Rank = 0,758; Impact Factor and Source Normalized Impact per Paper = 0,680; Eigenfactor Score and SCImago Journal & Country Rank = 0,367, Eigenfactor Score and Source Normalized Impact per Paper = 0,264, and SCImago Journal & Country Rank and Source Normalized Impact per Paper = 0,541. They were all statistically significant (p < 0,05). Conclusions: A moderate to high and significant correlation was found between Impact Factor, Eigenfactor Score, SCImago Journal & Country Rank and Source Normalized Impact per Paper(AU)


Assuntos
Humanos , Farmacologia , Farmácia , Toxicologia , Epidemiologia Descritiva , Estudos Retrospectivos , Bibliometria , Fator de Impacto de Revistas
2.
China Biotechnology ; (12)2006.
Artigo em Chinês | WPRIM | ID: wpr-685503

RESUMO

With the fast development of biopharmacy,transgenic chicken oviduct bioreactor is going to be the focus of people’s attention.For its excellent advantages,transgenic chicken will be one of rising industries in the field of biopharmacy and hot spot of scientific study.Now,the most successful method for producing transgenic chicken is mediated by retrovirus transferring gene into it, and transgenic chicken have been produced by this method.The advantages and methods of producing transgenic chicken by retrovirus,and the progress in transgenic chicken research were summarized.The significance and existent problems of transgenic chicken are also discussed.

3.
China Pharmacy ; (12)2005.
Artigo em Chinês | WPRIM | ID: wpr-526257

RESUMO

OBJECTIVE: To provide references for promoting the development of Chinese bio-pharmaceutical industry. METHODS: The development of American bio-pharmaceutical industry was analyzed, and their advanced experiences on bio-pharmaceutical industry policy were investigated and drawn. RESULTS & CONCLUSION: Bio-pharmaceutical industry policy is essential in ensuring fast development of bio-pharmaceutical industry. Based on the advanced experiences drawn from American, together with the practicality, we should formulate bio-pharmaceutical industry development policy that tailored to our own specific condition.

4.
China Pharmacy ; (12)2005.
Artigo em Chinês | WPRIM | ID: wpr-525606

RESUMO

OBJECTIVE:To discuss the developmental environments suitable for Chinese biopharmacy.METHODS:The developmental environments of Chinese pharmacy on policy,law,finance and information were analyzed in view of the char?acteristics of Chinese pharmacy.RESULTS&CONCLUSION:In order to push forward the developmental proceedings of Chinese biopharmacy,policies like Research&Development,products transfer,patent application and registration approval,industrialization,human resources management,marketing,international cooperation etc.of Chinese biopharmacy should be kept improving,and the environments on law,finance and information of biopharmacy should also be optimized.

5.
Chinese Journal of Medical Education Research ; (12)2003.
Artigo em Chinês | WPRIM | ID: wpr-622856

RESUMO

The main goal for the foundation of national life science and technology talents cultivating base(biopharmaceutical base) is building up perfect talents education systems to create elites with originality and carving-out ability.4 aspects including optimizing courses?improving teaching technics?enhancing practicing ability and reforming pattern of running school were mentioned to explore the cultivating system of biopharmaceutical base.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA